CM
ZYNE

Crystalline Management’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Crystalline Management’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-230,817
Closed -$294K – 140
2023
Q3 		$294K Buy
+230,817
New +$294K 0.21% 69